Related Experiment Videos
[Risk factors and intervention in cardiovascular diseases in general practice]
A Svilaas1, A Westheim, J E Kristoffersen
1Nymoen legekontor, Kongsberg.
Summary
This study found that most patients with established atherosclerotic disease did not receive adequate cholesterol-lowering treatment. Stronger emphasis on statin therapy is recommended to improve outcomes for these high-risk patients.
Area of Science:
- Cardiology
- Vascular Medicine
- Public Health
Context:
- Cross-sectional study of 707 patients with chronic ischemic heart disease or peripheral atherosclerotic disease in Norway (1994-1995).
- Data collected from 31 general practitioners.
- Patient demographics: 67% male, 33% female, 28% smokers.
Purpose:
- To assess the management of cardiovascular risk factors, particularly cholesterol levels, in patients with established atherosclerotic disease.
- To evaluate the adherence to treatment guidelines for hypertension, antithrombotic therapy, and lipid-lowering drugs.
Summary:
- While hypertension and antithrombotic treatments were generally adequate, over 90% of patients had high total and LDL-cholesterol levels indicating a need for statin therapy.
- Less than 20% of patients received statins, and few achieved treatment goals, highlighting a significant gap in care.
- The study underscores the underutilization of statins despite clear indications for their use in secondary prevention of atherosclerotic disease.
Impact:
- Recommends increased emphasis on serum cholesterol reduction in patients with established atherosclerotic disease.
- Highlights the need for improved lipid management in both primary care and specialist settings.
- Suggests that enhanced statin therapy could improve survival and reduce morbidity in patients with diagnosed atherosclerotic conditions.